Welcome to LookChem.com Sign In|Join Free
  • or
3-hydroxy-2-phenyl-1,3-thiazolidin-4-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

65655-88-1

Post Buying Request

65655-88-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65655-88-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 65655-88-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,6,5 and 5 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 65655-88:
(7*6)+(6*5)+(5*6)+(4*5)+(3*5)+(2*8)+(1*8)=161
161 % 10 = 1
So 65655-88-1 is a valid CAS Registry Number.

65655-88-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-hydroxy-2-phenyl-1,3-thiazolidin-4-one

1.2 Other means of identification

Product number -
Other names 4-thiazolidinone,3-hydroxy-2-phenyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65655-88-1 SDS

65655-88-1Downstream Products

65655-88-1Relevant academic research and scientific papers

Acylative Kinetic Resolution of Cyclic Hydroxamic Acids

Yin, Jingwei,Straub, Matthew R.,Liao, Julian D.,Birman, Vladimir B.

, p. 1546 - 1549 (2022/03/01)

Racemic cyclic hydroxamic acids bearing an aryl substituent adjacent to the hydroxyl group undergo effective acylative kinetic resolution promoted by benzotetramisole (BTM).

Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias

Jackson, Chris M.,Blass, Benjamin,Coburn, Keith,Djandjighian, Laurent,Fadayel, Gina,Fluxe, Andrew J.,Hodson, Steven J.,Janusz, John M.,Murawsky, Michael,Ridgeway, James M.,White, Ronald E.,Wu, Shengde

, p. 282 - 284 (2007/10/03)

Blockade of the Kv1.5 ion channel is a potentially atrial-selective avenue for the treatment of atrial fibrillation and atrial flutter. The development and biological evaluation of a series of thiazolidine-based blockers of Kv1.5 is described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 65655-88-1